- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dabrafenib
Total 163 results
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsCompleted
-
Universitair Ziekenhuis BrusselCompleted
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
University Medical Center GroningenTerminated
-
GlaxoSmithKlineCompleted
-
Fondazione Melanoma OnlusWithdrawn
-
Novartis PharmaceuticalsRecruitingBRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid TumorJapan
-
Novartis PharmaceuticalsCompletedMalignant MelanomaPortugal
-
Spirita Oncology, LLCUniversity of ArizonaTerminatedBrain Metastases | Malignant MelanomaUnited States
-
Leiden University Medical CenterNovartisRecruitingAnaplastic Thyroid CancerNetherlands
-
Novartis PharmaceuticalsAvailable
-
Poitiers University HospitalCompletedUnresecable Stage IIIc or IV MelanomaFrance
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | BRAF V600 Mutation | MET Exon 14 MutationChina
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsRecruiting
-
EuMelaReg gGmbHActive, not recruiting
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Japan, Netherlands, China, Thailand
-
Novartis PharmaceuticalsAvailable
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
Eva Marie Erfurth, MD, PhDNovartisRecruiting
-
Novartis PharmaceuticalsRecruitingGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Neurofibromatosis Type 1 | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma... and other conditionsUnited States, Belgium, Spain, Denmark, Germany, Czechia, Italy, Australia, Russian Federation, France, Netherlands, Japan, Canada, Finland, Sweden, United Kingdom, Argentina, Israel, Brazil
-
Haukeland University HospitalBerGenBio ASAActive, not recruiting
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
GlaxoSmithKlineTerminatedMelanoma and Brain MetastasesUnited States, Australia
-
University of UtahTerminatedStage III or IV MelanomaUnited States
-
National University Hospital, SingaporeSingapore General HospitalUnknown
-
Zhejiang Cancer HospitalNot yet recruitingAdvanced Colorectal CancerChina
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Novartis PharmaceuticalsRecruitingDifferentiated Thyroid CancerChina, Korea, Republic of, Taiwan, India, Malaysia, Turkey, Canada, Vietnam, Argentina, Brazil, Mexico, United States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma (Locally Advanced) | Stage IIC Melanoma (Locally Advanced) | Stage IV Melanoma (Limited, Resectable)United States
-
Olivia Newton-John Cancer Research InstituteThe Alfred; Austin Health; Peter MacCallum Cancer Centre, Australia; Royal Brisbane... and other collaboratorsRecruiting
-
University of MichiganCompleted
-
Bhavana KondaNational Comprehensive Cancer NetworkActive, not recruitingInsular Thyroid Cancer | Recurrent Thyroid Cancer | Papillary Thyroid Cancer | Follicular Thyroid CancerUnited States
-
TriHealth Inc.TriHealth Cancer Institute; TriHealth Surgical Institute; TriHealth Ultrasound... and other collaboratorsWithdrawnMelanoma (Skin) | Tumor Skin | BRAF Gene Mutation | Melanoma Stage IIIb-IVM1a | Metastasis SkinUnited States
-
Novartis PharmaceuticalsCompleted
-
National Cancer Institute (NCI)WithdrawnDabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 MutationsErdheim-Chester DiseaseUnited States
-
University Hospital, EssenRecruitingMetastatic Thyroid CancerGermany
-
National Human Genome Research Institute (NHGRI)CompletedBRAF V600E MutationUnited States
-
BayerCompletedProstatic Neoplasms, Castration-ResistantBelgium
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNSCLC | Advanced Cancer | Stage IV NSCLC | BRAF V600E Mutation | Stage IIIB NSCLC
-
Manisha ShahNational Comprehensive Cancer NetworkCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8United States
-
Novartis PharmaceuticalsCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced BRAF Mutant MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis; National Comprehensive Cancer NetworkCompleted
-
Novartis PharmaceuticalsCompletedNeoplasms, BrainUnited States, France, Germany, Israel, Canada, Australia, Denmark, Spain, United Kingdom, Italy
-
GlaxoSmithKlineCompletedMelanoma and Brain MetastasesAustralia, Germany, United States, Canada, Italy, France
-
Aprea TherapeuticsJules Bordet InstituteTerminated
-
GlaxoSmithKlineTerminated